Forefront Wealth Partners’s Elevance Health ELV Stock Holding History
Bought
Maintained
Sold
Other funds holding ELV
VCM
VPM
Forefront Wealth Partners's ELV Position: Q1 2026 in Review
Forefront Wealth Partners reduced its Elevance Health (ELV) stake by 3.2% in Q1 2026, selling an estimated $7.56K and leaving 695 shares worth $203K. The position accounts for 0.09% of the portfolio, ranked #159.
Forefront Wealth Partners first reported a position in ELV in Q4 2024 and has held it in 6 quarters since. The position peaked at $343K in Q2 2025. 1,462 funds tracked by Wall St. Rank hold ELV as of Q1 2026.
- Forefront Wealth Partners held 695 shares of Elevance Health worth $203K as of Q1 2026.
- Forefront Wealth Partners sold 23 Elevance Health shares in Q1 2026, an estimated $7.56K.
- Elevance Health made up 0.09% of Forefront Wealth Partners's portfolio in Q1 2026, its #159 holding.
- Forefront Wealth Partners first reported a position in Elevance Health in Q4 2024 and has held it in 6 quarters since.
- Forefront Wealth Partners's Elevance Health position peaked at $343K in Q2 2025.
- 1,462 funds tracked by Wall St. Rank held Elevance Health as of Q1 2026.
Based on Forefront Wealth Partners's 13F filing for Q1 2026, filed 17 Apr 2026.